Evidence map›Paper›PMID 38905298›Full record

ArticleRenal failure2024

A lower eGFR

Yan Yang, Bixia Yang, Shizhu Zhao, Shusu Liu, Hua Zhou, Ning Xu, Min Yang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Renal failure, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yan YangDepartment of Nephrology, The Third Affiliated Hospital of Soochow University, Changzhou, China.
Bixia YangDepartment of Nephrology, The Third Affiliated Hospital of Soochow University, Changzhou, China.
Shizhu ZhaoDepartment of Nephrology, The Third Affiliated Hospital of Soochow University, Changzhou, China.
Shusu LiuDepartment of Nephrology, The Third Affiliated Hospital of Soochow University, Changzhou, China.
Hua ZhouDepartment of Nephrology, The Third Affiliated Hospital of Soochow University, Changzhou, China.
Ning XuDivision of Clinical Chemistry and Pharmacology, Department of Laboratory Medicine, Lund University, Lund, Sweden.
Min YangDepartment of Nephrology, The Third Affiliated Hospital of Soochow University, Changzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCardiovascular disease (CVD) is the leading cause of mortality in type 2 diabetes mellitus (T2DM) patients. Shrunken pore syndrome (SPS) is defined as eGFR

methodsPatients aged 18-80 years who were newly diagnosed with T2DM were included in this retrospective study. Ordinal logistic regression analysis was used to investigate the association between risk factors of T2DM and FRS. A Generalized Linear Model was used to calculate odds ratios (OR) and 95% confidence intervals (CI).

resultsThere were 270 patients included in the study. Only 27 patients (10%) met the diagnostic criteria of SPS. Ordinal logistic regression analysis showed that SPS was not correlated with FRS risk (OR = 1.99, 95%CI = 0.94-4.23,

conclusionsIn the current study, no significant association between SPS and FRS was identified. However, lower eGFR

Indexed as

Cardiovascular DiseasesCreatinineCystatin CDiabetes Mellitus, Type 2Glomerular Filtration RateAdolescentAdultAgedAged, 80 and overChinaEast Asian PeopleFemaleHeart Disease Risk FactorsHumansLogistic ModelsMaleCreatinineCystatin CeGFRframingham risk scoreshrunken pore syndromeType 2 diabetes mellitus

Identifiers

PMID38905298
PMCPMC11195453

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.